XML 41 R31.htm IDEA: XBRL DOCUMENT
v3.22.4

Segment Information (Tables) | 9 Months Ended
--- | ---
Jan. 28, 2023
Segment Reporting [Abstract] |
Schedule of Reportable Segments | The tables below present information about the Company’s reportable segments:
|  | Three Months Ended January 28, 2023 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net sales |  | $ | 178.6 |  |  | $ | 100.8 |  |  | $ | 12.1 |  |  | $ | 0.6 |  |  | $ | (12.0 | ) |  | $ | 280.1 |
Transfers between segments |  |  | (2.1 | ) |  |  | (9.8 | ) |  |  | (0.1 | ) |  |  | — |  |  |  | 12.0 |  |  |  | — |
Net sales to unaffiliated customers |  | $ | 176.5 |  |  | $ | 91.0 |  |  | $ | 12.0 |  |  | $ | 0.6 |  |  | $ | — |  |  | $ | 280.1 |
Income (loss) from operations |  | $ | 18.7 |  |  | $ | 22.3 |  |  | $ | 1.0 |  |  | $ | (1.8 | ) |  | $ | (12.9 | ) |  | $ | 27.3 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.8 |
Other expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.5 |
Pre-tax income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 23.0 |
|  | Three Months Ended January 29, 2022 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net sales |  | $ | 196.9 |  |  | $ | 81.6 |  |  | $ | 15.2 |  |  | $ | 1.0 |  |  | $ | (3.1 | ) |  | $ | 291.6 |
Transfers between segments |  |  | (1.5 | ) |  |  | (1.6 | ) |  |  | — |  |  |  | — |  |  |  | 3.1 |  |  |  | — |
Net sales to unaffiliated customers |  | $ | 195.4 |  |  | $ | 80.0 |  |  | $ | 15.2 |  |  | $ | 1.0 |  |  | $ | — |  |  | $ | 291.6 |
Income (loss) from operations |  | $ | 24.5 |  |  | $ | 17.7 |  |  | $ | 2.1 |  |  | $ | (1.6 | ) |  | $ | (12.9 | ) |  | $ | 29.8 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.7 |
Other income, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (4.4 | )
Pre-tax income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 33.5 |
|  | Nine Months Ended January 28, 2023 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net sales |  | $ | 554.2 |  |  | $ | 302.3 |  |  | $ | 39.2 |  |  | $ | 2.4 |  |  | $ | (19.7 | ) |  | $ | 878.4 |
Transfers between segments |  |  | (4.2 | ) |  |  | (15.4 | ) |  |  | (0.1 | ) |  |  | — |  |  |  | 19.7 |  |  |  | — |
Net sales to unaffiliated customers |  | $ | 550.0 |  |  | $ | 286.9 |  |  | $ | 39.1 |  |  | $ | 2.4 |  |  | $ | — |  |  | $ | 878.4 |
Income (loss) from operations |  | $ | 56.8 |  |  | $ | 69.7 |  |  | $ | 4.2 |  |  | $ | (4.7 | ) |  | $ | (44.1 | ) |  | $ | 81.9 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.3 |
Other income, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (1.7 | )
Pre-tax income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 82.3 |
|  | Nine Months Ended January 29, 2022 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net sales |  | $ | 591.0 |  |  | $ | 245.5 |  |  | $ | 45.9 |  |  | $ | 2.6 |  |  | $ | (10.1 | ) |  | $ | 874.9 |
Transfers between segments |  |  | (3.8 | ) |  |  | (6.3 | ) |  |  | — |  |  |  | — |  |  |  | 10.1 |  |  |  | — |
Net sales to unaffiliated customers |  | $ | 587.2 |  |  | $ | 239.2 |  |  | $ | 45.9 |  |  | $ | 2.6 |  |  | $ | — |  |  | $ | 874.9 |
Income (loss) from operations |  | $ | 75.4 |  |  | $ | 56.7 |  |  | $ | 7.6 |  |  | $ | (4.6 | ) |  | $ | (38.0 | ) |  | $ | 97.1 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2.9 |
Other income, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (7.1 | )
Pre-tax income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 101.3 |
(in millions) |  | January 28, 2023 |  |  | April 30, 2022 |
Identifiable assets: |  |  |  |  |  |
Automotive |  | $ | 713.9 |  |  | $ | 689.8 |
Industrial |  |  | 459.5 |  |  |  | 455.3 |
Interface |  |  | 120.5 |  |  |  | 108.1 |
Medical |  |  | 6.4 |  |  |  | 7.9 |
Eliminations/Corporate |  |  | 128.2 |  |  |  | 128.0 |
Total identifiable assets |  | $ | 1,428.5 |  |  | $ | 1,389.1 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration